Therefore, to demonstrate systemic activities for secreted FKN, 3LL‐FKN cells were subcutaneously implanted in mice on the left flank (inoculation side), followed by injection of unmodified 3LL cells on the right flank (target tumor side) 1 week later (Fig 5A). This evidence concerns the gene CX3CL1 and neoplasm.